Relevance to clinical features and independent contribution to both overall and disease-free survival highlighted the importance of the translation initiation factor subunit EIF3D and the splicing factor HNRNPA2B1 in prostate cancer. The gene discussed is HNRNPA2B1; the disease is prostate carcinoma.